for patients with superficial bladder tumours intravesical treatment or prophylaxis with thiotepa , doxorubicin , mitomycin c or bacillus calmette-guerin has added a useful dimension to management , although the precise indications for each regimen remain to be better defined .
C0005695
bladder tumours
C0013089
doxorubicin